Portable Biosensor With Vertical Graphene FET Array for Field Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biosensing technologies require complex laboratory equipment, specialized personnel, and time-consuming procedures, limiting their use in field or point-of-care settings, and face challenges in achieving sensitivity, specificity, and reliability, as well as issues with sensor stability, cross-reactivity, and the ability to detect multiple analytes simultaneously.
Innovation Solution
A portable biosensor system utilizing a vertical graphene field effect transistor (FET) array with integrated microfluidics and automated measurement capabilities, featuring three-dimensional graphene structures for increased surface area and binding sites, and advanced features like current drift correction and programmable voltage sweeping.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional biosensing technologies are used, then detection sensitivity and specificity can be achieved, but the system complexity and operational requirements increase significantly
Solution Approach 1:
The patent transitions from traditional planar sensor surfaces to three-dimensional vertical graphene structures. This dimensional change increases the surface area and number of binding sites without proportionally increasing device footprint, thereby maintaining high detection sensitivity while reducing overall system complexity and enabling portable deployment
Solution Approach 2:
The patent applies chemical functionalization specifically to the vertical graphene structures to create localized bioreceptor binding sites. This localized modification enhances detection specificity at the sensor surface without requiring complex modifications throughout the entire system, resolving the contradiction between sensitivity and system complexity
2Measurement precision
If laboratory-based biosensing methods are used, then accurate analyte detection is achieved, but the time required for analysis and operational complexity increase
Solution Approach 1:
The patent replaces complex mechanical laboratory equipment with an electronic field-effect transistor-based detection system. The vertical graphene FET structures directly transduce analyte binding events into electrical signals, eliminating time-consuming mechanical操作步骤 and enabling rapid point-of-care testing while maintaining laboratory-grade accuracy
Solution Approach 2:
The patent incorporates preliminary chemical functionalization of the vertical graphene structures with specific bioreceptors during manufacturing. This pre-preparation of binding sites eliminates the need for time-consuming sample preparation and reagent addition steps during actual testing, reducing analysis time while preserving detection accuracy
3Ease of operation
If portable biosensor systems are developed, then field deployability is improved, but sensitivity and reliability decrease
Solution Approach 1:
The patent uses vertical three-dimensional graphene structures that provide enhanced surface area and binding capacity in a compact form factor. This dimensional approach maintains high detection sensitivity typically found in laboratory systems while enabling portable, field-deployable device design
Solution Approach 2:
The patent employs composite structures combining vertical graphene with chemical functionalization layers containing specific bioreceptors. This composite material approach enhances both sensitivity and selectivity while maintaining a compact structure suitable for portable applications in field settings
4Area of stationary object
If vertical graphene structures are implemented, then surface area and binding sites increase, but manufacturing complexity increases
Solution Approach 1:
The patent implements vertical three-dimensional graphene structures grown directly on the sensor substrate. This vertical growth approach achieves high surface area-to-footprint ratio without requiring complex assembly of multiple components, simplifying the overall manufacturing process while maximizing binding site availability
Solution Approach 2:
The patent develops a universal fabrication process for vertical graphene structures that can be applied across different sensor configurations and analyte types. This standardized approach reduces manufacturing complexity by eliminating the need for application-specific structural modifications, enabling scalable production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system achieves high sensitivity and specificity in a compact, field-deployable format, enabling rapid and accurate detection of biological analytes without the need for specialized operators, suitable for healthcare diagnostics, environmental monitoring, and food safety testing.
Implementation Method 1
the functionalization layer includes bioreceptors configured to bind to specific target analytes
Implementation Method 2
vertical graphene field effect transistor (FET) array
Data Source
AI summary
The present disclosure provides an innovative biosensor system utilizing three-dimensional vertical graphene structures for highly sensitive analyte detection in field-deployable applications. The vertical graphene structures may be formed in-situ directly on the sensor substrate, potentially enabling on-site fabrication and customization. These structures, with their increased surface area and unique tree-like morphology, may offer improved binding sites for bioreceptors compared to conventional flat graphene sensors. This biosensor design may address limitations of existing biosensors by combining enhanced surface area, controlled sample handling, and advanced measurement techniques in a single, field-portable device. The potential for in-situ graphene formation may allow for rapid sensor deployment and adaptation. Additionally, the system's portability may enable on-site analysis in remote locations, potentially reducing the need for sample transport and laboratory-based testing.